GIULI, MARIA VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 604
EU - Europa 393
AS - Asia 134
AF - Africa 11
SA - Sud America 3
Totale 1.145
Nazione #
US - Stati Uniti d'America 603
IT - Italia 253
IN - India 47
DE - Germania 37
SG - Singapore 37
CN - Cina 36
SE - Svezia 31
BG - Bulgaria 17
IE - Irlanda 12
TG - Togo 9
FI - Finlandia 7
GB - Regno Unito 6
CH - Svizzera 5
FR - Francia 5
IR - Iran 5
DK - Danimarca 4
HK - Hong Kong 4
RO - Romania 4
BE - Belgio 3
GR - Grecia 3
AR - Argentina 2
ES - Italia 2
KR - Corea 2
VN - Vietnam 2
AL - Albania 1
CL - Cile 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PT - Portogallo 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.145
Città #
Rome 129
Chandler 87
Fairfield 65
Ashburn 44
Woodbridge 40
Seattle 34
Wilmington 26
Cambridge 25
Houston 24
New York 24
Princeton 22
Grafing 21
Pune 17
Beijing 16
Sofia 15
Des Moines 14
Dublin 12
Singapore 12
Redmond 10
Fremont 9
Lomé 9
Boardman 8
San Paolo di Civitate 8
Andover 7
Castellana Sicula 7
Chicago 7
Ann Arbor 6
Cagliari 6
Dearborn 6
Lawrence 6
Mestre 6
Plano 6
San Diego 6
Stolberg 6
Boston 5
Helsinki 5
Millbury 5
St-Legier-La Chiesaz 5
Bari 4
Bell Gardens 4
Bühl 4
Hong Kong 4
Kunming 4
Arezzo 3
Brussels 3
Castel Gandolfo 3
Guangzhou 3
Milan 3
Padova 3
Phoenix 3
Alora 2
Birmingham 2
Bracciano 2
Cadoneghe 2
Copenhagen 2
Federal 2
Florence 2
Frederiksberg 2
Fumone 2
Jesi 2
Jinan 2
London 2
Lynchburg 2
Modena 2
Nanjing 2
Norwalk 2
Nürnberg 2
Settimo Torinese 2
Timisoara 2
Alatri 1
Ariccia 1
Berlin 1
Bishkek 1
Bologna 1
Chengdu 1
Hanoi 1
Hefei 1
Hendon 1
Ho Chi Minh City 1
Hyderabad 1
Kashan 1
Langfang 1
Lauria 1
Los Angeles 1
Mannheim 1
Marino 1
Mexico City 1
Miglianico 1
Nettuno 1
Parma 1
Redwood City 1
Reggio Emilia 1
Riga 1
Saint Charles 1
San Jose 1
Santiago 1
Shenyang 1
Shimla 1
Silverton 1
Tiranë 1
Totale 870
Nome #
Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression 142
NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest 122
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response 97
Notch signaling activation as a hallmark for triple-negative breast cancer subtype 94
Getting insights into the multi-faceted role of Notch3 in different tumor contexts 86
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. 67
Current trends in ATRA delivery for cancer therapy 62
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer. A novel mechanism of intrinsic drug resistance 58
Opsonin-deficient nucleoproteic corona endows unPEGylated liposomes with stealth properties in vivo 57
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential 50
Targeting the ER/UPR signalling in Notch3-overexpressing T-cell acute lymphoblastic leukemia. 47
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response 46
Cytotoxic activity of Juglone against Notch3-overexpressing T-cell acute lymphoblastic leukemia: targeting the ER/UPR signaling 45
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application 40
Molecular basis of Notch3-Pin1 functional crosstalk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment 38
Getting insights into Pin1-Notch3 functional crosstalk in ovarian cancer 38
Potential targeted therapy for T-cell acute lymphoblastic leukemia: perturbing ER/UPR signaling via Notch3 down-regulation 30
Role of Notch3 in sustaining UPR signaling in Notch3-overexpressing T-cell acute lymphoblastic leukemia. 29
Notch signaling in female cancers. A multifaceted node to overcome drug resistance 29
ProAlanase is an effective alternative to trypsin for proteomics applications and disulfide bond mapping 29
pH-sensitive niosomes for ATRA delivery. A promising approach to inhibit Pin1 in high-grade serous ovarian cancer 20
Totale 1.226
Categoria #
all - tutte 3.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020185 14 19 0 6 13 17 37 31 15 14 15 4
2020/2021163 7 5 3 21 18 10 6 7 15 63 8 0
2021/2022158 4 10 3 12 22 2 6 23 22 15 20 19
2022/2023307 43 42 10 22 41 52 7 30 29 6 8 17
2023/2024288 7 17 7 7 33 84 29 35 2 37 19 11
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 1.226